From: Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies
TITLE | PATENT NUMBER | PUBLICATION DATE |
---|---|---|
ADMINISTRATION OF AN INHIBITOR OF HDAC AND AN HMT INHIBITOR | WO2009126537 | 15/10/2009 |
USE OF METHYLATION STATUS OF MINT LOCI AND TUMOR-RELATED GENES AS A MARKER FOR MELANOMA AND BREAST CANCER | WO2009086472 | 09/07/2009 |
GENE METHYLATION IN DIAGNOSIS OF MELANOMA | US2009170083 | 02/07/2009 |
ADMINISTRATION OF AN INHIBITOR OF HDAC | WO2009067500 | 28/05/2009 |
MARKERS FOR MELANOMA | US2009093424 | 09/04/2009 |
USE OF HDAC INHIBITORS FOR THE TREATMENT OF MELANOMA | CA2684114 | 20/11/2008 |
UTILITY OF HIGH MOLECULAR WEIGHT MELANOMA ASSOCIATED ANTIGEN IN DIAGNOSIS AND TREATMENT OF CANCER | WO2008121125 | 09/10/2008 |
INHIBITORS OF DNA METHYLATION IN TUMOR CELLS | US2008138329 | 12/06/2008 |
METHODS AND PRODUCTS FOR DIAGNOSING CANCER | WO2008066878 | 05/06/2008 |
UTILITY OF HIGH MOLECULAR WEIGHT MELANOMA ASSOCIATED ANTIGEN IN DIAGNOSIS AND TREATMENT OF CANCER | WO2007123697 | 01/11/2007 |
MARKERS FOR MELANOMA | EP1840227 | 03/10/2007 |
MARKERS FOR MELANOMA | WO2006092610 | 08/09/2006 |
COMBINED USE OF PRAME INHIBITORS AND HDAC INHIBITORS | CA2553886 | 18/08/2005 |
USE OF BAGE (B MELANOMA ANTIGENS) LOCI AS TUMOUR MARKERS | WO2004101822 | 25/11/2004 |